Pilkocospharm Co., Ltd. Signs MOU with Gyeongbuk Silkworm & Insect Business Center for Joint Development of Next-Generation Bio-Fillers

Pilkocospharm Co., Ltd. (CEO Jung Hoon-cheol) is partnering with the Gyeongbuk Silk & Insect Business Center to embark on the development of next-generation bio-fillers. On June 12, the two organizations signed a Memorandum of Understanding (MOU) at the Silkworm & Insect Business Center in Sangju, Gyeongbuk, agreeing to collaborate on the development of dermal fillers using insect-derived biological resources, including silkworm cocoons.

This agreement aims to strengthen cooperation in a wide range of areas, including research and development of new materials, product commercialization, and advancement into the global eco-friendly beauty market.

Introduction to Pilkocospharm Co., Ltd. and Its Core Competencies

Pilkocospharm Co., Ltd. is a rapidly growing company in the domestic and international markets, specializing in functional cosmetics and medical aesthetics, with strong R&D-based manufacturing capabilities.

The company’s product portfolio and strengths include:

• Specialized product lines such as skin boosters, injectable ampoules, lifting solutions, and hair-loss treatments

• Consumer-friendly home care cosmetics including ampoules, mask packs, and repair creams

• Medical device-integrated products for hospitals and aesthetics

• Freeze-dried ampoule and powder formulation development with stable, high-functionality active ingredients

Recently, Pilkocospharm Co., Ltd. has focused on developing preservative-free, high-purity skin boosters and ampoules using lyophilization (freeze-drying) technology. This allows the biological stability and efficacy of active ingredients to be maximized by activating the formulations just before use - a key technology that offers a competitive edge in the high-end medical and aesthetic markets.

Key formulation expertise includes:

• Ingredients such as PLLA (poly-L-lactic acid), peptides, exosomes, and more

• A full-service OEM/ODM system

• Mitochondrial activation & skin homeostasis

The company also holds multiple international certifications, proving its competitiveness:

• ISO 9001 (Quality Management)

• ISO 14001 (Environmental Management)

• ISO 13485 (Medical Device Quality Management)

• ISO 45001 (Occupational Health and Safety Management)

• ISO 22716 (GMP, Good Manufacturing Practices)

Pilkocospharm Co., Ltd. has secured global certifications such as the European CPNP, China’s NMPA, and the U.S. MoCRA and is actively collaborating with buyers from 20 countries.

CEO Jung Hoon-cheol stated, “This agreement marks a significant turning point, accelerating the convergence of Pilkocospharm Co., Ltd.'s science-based functionality with eco-friendly natural raw materials.” An official from the Gyeongbuk Silk & Insect Business Center added, “This collaboration is meaningful not only for the industrialization of research but also for revitalizing the local bio-industry ecosystem. We aim to create a new business model by integrating our technology with the bio-filler.”

Moving forward, the two organizations plan to establish a sustainable and mutually beneficial partnership through ongoing technology exchanges, joint research, prototype development, and participation in global exhibitions.

[대한민국영어신문 나윤재 기자]